Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Clover Health Investments (7QD) Stock Price & Analysis

7QD Stock Chart & Stats

€3.86-€0.33(-7.88%)
At close: 5:30 PM GMT+1
EUR 3.75EUR 4EUR 4.25EUR 4.524 Jul12 Aug18 Aug6 Oct19 Oct
Day’s Range
EUR 3.86 - EUR 4.00
52-Week Range
EUR 1.41 - EUR 4.92
Previous Close
EUR 4.19
Volume
272
Average Volume (3M)
60
Market Cap
EUR 2.11B
Enterprise Value
EUR 2.86B
Total Cash (Recent Filing)
EUR 201.32M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
0.45
Next Earnings
Nov 04, 2026 (Est.)
EPS Estimate
-0
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Higher Medicare Advantage Star Ratings

The higher Star ratings can improve Clover’s Medicare Advantage economics and commercial flexibility by supporting payment levels, year-round PPO enrollment, and more competitive benefits. Sustained HEDIS leadership also supports the credibility of its technology-enabled care model and member proposition.

Strong Membership And Revenue Growth

Rapid membership expansion is translating into substantial revenue growth, demonstrating stronger market adoption of Clover’s Medicare Advantage offering. Greater scale can support broader operating leverage, deepen provider and market density, and create a larger base over which care-management capabilities can improve economics.

Debt-Free Balance Sheet And Positive Cash Flow

A debt-free balance sheet and strong cash position give Clover meaningful financial flexibility while it funds membership growth and technology investment. Positive operating cash flow also reduces reliance on external financing, allowing management to pursue its strategy with greater resilience through normal insurance-cycle volatility.

Bears Say

Profitability Not Yet Consistent

Despite recent quarterly profitability and improved margins, Clover has not yet demonstrated consistent full-year earnings power. Continued losses leave results sensitive to medical-cost changes, pricing and utilization, while any delay in reaching durable profitability could constrain reinvestment and weaken equity over time.

Early-Stage Cohort Margin Pressure

A large share of members remains in the first two years of Clover’s lifecycle, when economics are less mature and margins are expected to be pressured. The model depends on cohort improvement over time, so slower maturation or weaker medical-cost performance could delay the expected profitability benefits.

CMS Appeal Creates Payment Uncertainty

The appeal creates regulatory uncertainty around the methodology supporting Clover’s 5-Star PPO rating and the resulting payment-year benefits. An adverse outcome could reduce enrollment flexibility, competitive benefit investment, or reimbursement support, making future growth and margin planning less predictable.

Clover Health Investments News

7QD FAQ

What was Clover Health Investments’s price range in the past 12 months?
Clover Health Investments lowest stock price was €1.41 and its highest was €4.92 in the past 12 months.
What is Clover Health Investments’s market cap?
Clover Health Investments’s market cap is €2.11B.
When is Clover Health Investments’s upcoming earnings report date?
Clover Health Investments’s next earnings report is estimated for Nov 04, 2026 (not yet confirmed), which is in 3 days.
How were Clover Health Investments’s earnings last quarter?
Clover Health Investments released its earnings results on Aug 05, 2026. The company reported €0.045 earnings per share for the quarter, beating the consensus estimate of €0.035 by €0.01.
Is Clover Health Investments overvalued?
According to Wall Street analysts Clover Health Investments’s price is currently Undervalued.
Does Clover Health Investments pay dividends?
Clover Health Investments does not currently pay dividends.
What is Clover Health Investments’s EPS estimate?
Clover Health Investments’s EPS estimate is -0.00.
How many shares outstanding does Clover Health Investments have?
Clover Health Investments has 435,441,350 shares outstanding.
What happened to Clover Health Investments’s price movement after its last earnings report?
Clover Health Investments reported an EPS of €0.045 in its last earnings report, beating expectations of €0.035. Following the earnings report the stock price went up 8.078%.
Which hedge fund is a major shareholder of Clover Health Investments?
Hedge funds hold Clover Health Investments shares: the largest hedge-fund position in Clover Health Investments is 1,635,583,003 shares, and hedge funds increased their holdings by 1.4M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology